Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Nancy Jean Cox to Vaccines, Attenuated

This is a "connection" page, showing publications Nancy Jean Cox has written about Vaccines, Attenuated.

 
Connection Strength
 
 
 
0.599
 
  1. Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, Rekstin AR, Beljaev AL, Bragina VE, Cox N, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993 Oct; 168(4):881-7.
    View in: PubMed
    Score: 0.130
  2. Fiore AE, Bridges CB, Cox NJ. Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:43-82.
    View in: PubMed
    Score: 0.094
  3. Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? N Engl J Med. 2007 Feb 15; 356(7):729-31.
    View in: PubMed
    Score: 0.082
  4. Cox NJ, Maassab HF, Kendal AP. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug; 97(1):190-4.
    View in: PubMed
    Score: 0.049
  5. Klimov AI, Egorov AY, Gushchina MI, Medvedeva TE, Gamble WC, Rudenko LG, Alexandrova GI, Cox NJ. Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol. 1995 Jun; 76 ( Pt 6):1521-5.
    View in: PubMed
    Score: 0.037
  6. Isakova-Sivak I, Chen LM, Bourgeois M, Matsuoka Y, Voeten JT, Heldens JG, van den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Clin Vaccine Immunol. 2014 May; 21(5):722-31.
    View in: PubMed
    Score: 0.034
  7. Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM. Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
    View in: PubMed
    Score: 0.028
  8. Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch Hv, Klimov A, Rudenko L, Cox NJ, Donis RO. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology. 2011 Apr 10; 412(2):297-305.
    View in: PubMed
    Score: 0.027
  9. Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
    View in: PubMed
    Score: 0.025
  10. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
    View in: PubMed
    Score: 0.024
  11. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 Jul 28; 55(RR-10):1-42.
    View in: PubMed
    Score: 0.020
  12. Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine. 2006 Nov 17; 24(47-48):6859-66.
    View in: PubMed
    Score: 0.020
  13. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004 May 28; 53(RR-6):1-40.
    View in: PubMed
    Score: 0.017
  14. Rudenko LG, Arden NH, Grigorieva E, Naychin A, Rekstin A, Klimov AI, Donina S, Desheva J, Holman RC, DeGuzman A, Cox NJ, Katz JM. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 2000 Sep 15; 19(2-3):308-18.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.